These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 4. Single antituberculous drug chemotherapy against conventional mice infected intravenously with Mycobacterium kansasii]. Lee Y; Kuze F; Maekawa N; Suzuki Y Kekkaku; 1982 Jun; 57(6):343-52. PubMed ID: 7176298 [No Abstract] [Full Text] [Related]
7. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 5. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium kansasii]. Lee Y; Kuze F; Maekawa N; Suzuki Y Kekkaku; 1982 Jul; 57(7):369-77. PubMed ID: 7176299 [No Abstract] [Full Text] [Related]
8. [Experimental infections caused by atypical mycobacteria. 6. Experimental Mycobacterium fortuitum infection and trial chemotherapy]. Kuze F; Lee Y; Maekawa N; Suzuki Y Kekkaku; 1983 Jul; 58(7):385-93. PubMed ID: 6656072 [No Abstract] [Full Text] [Related]
9. Chemotherapy of infections caused by atypical mycobacteria. Gialdroni-Grassi G; Grassi C Antimicrob Agents Chemother (Bethesda); 1965; 5():1074-8. PubMed ID: 5883402 [No Abstract] [Full Text] [Related]
10. [Therapeutic results in lung diseases caused by atypical mycobacteria]. Fischer P; Schilling W Z Erkr Atmungsorgane; 1984; 162(1):26-9. PubMed ID: 6202070 [TBL] [Abstract][Full Text] [Related]
11. [Studies on discharge of atypical myocbacteria in ambulatory patients and treatment of pulmonary disease caused by atypical mycobacteria (so-called atypical mycobacteriosis)]. Yamaguchi T; Toyohara M Kekkaku; 1967 Jul; 42(7):245-50. PubMed ID: 5583607 [No Abstract] [Full Text] [Related]
12. B663 and ethambutol in the treatment of Battey disease. Bull PR Med J Aust; 1968 Mar; 1(12):511. PubMed ID: 5647373 [No Abstract] [Full Text] [Related]
13. [Experimental therapy with so-called "minor" tuberculostatics]. Freerksen E Wien Med Wochenschr; 1966 Oct; 116(42):874-7. PubMed ID: 6005730 [No Abstract] [Full Text] [Related]
14. The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment. Heginbothom ML Int J Tuberc Lung Dis; 2001 Jun; 5(6):539-45. PubMed ID: 11409581 [TBL] [Abstract][Full Text] [Related]
15. Nontuberculous mycobacteria: a case report and review of the literature. McLellan RA; Bell R; Paulman PM Nebr Med J; 1986 Mar; 71(3):60-4. PubMed ID: 3703052 [No Abstract] [Full Text] [Related]
16. Mycobacterium xenopi and mycobacteriosis. A clinical bacteriologic report. Elston HR; Duffy JP Am Rev Respir Dis; 1973 Oct; 108(4):944-9. PubMed ID: 4582438 [No Abstract] [Full Text] [Related]
17. [Clinical and bacteriological comparisons in patients excreting atypical mycobacteria]. Moisescu V; Fanea E; Popescu M; Petrescu G; Cornea G; Cordea I; Florescu S; Vaida T Ftiziologia; 1971; 20(3):249-57. PubMed ID: 4950549 [No Abstract] [Full Text] [Related]
18. [Principles of rational tuberculosis chemotherapy]. Khomenko AG Antibiotiki; 1980 Jul; 25(7):534-9. PubMed ID: 7406466 [TBL] [Abstract][Full Text] [Related]
19. [Isoxyl and T283 in the treatment of photochromogenic infections in mice]. Burjanová B; Dornetzhuber V Z Tuberk Erkr Thoraxorg; 1967; 127(1):123-5. PubMed ID: 5632189 [No Abstract] [Full Text] [Related]
20. Osteoarticular tuberculosis: current diagnosis and treatment. Sequeira W; Co H; Block JA Am J Ther; 2000 Nov; 7(6):393-8. PubMed ID: 11304648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]